Cardiology Fellow @uw_cvm 🫀@hERGologie lab 🔬Physician-scientist studying ion channels in arrhythmia 🤓
Madison, WI
- Tweets 5,126
- Following 9,213
- Followers 8,428
- Likes 30,310
Science still has expertise; what it’s lost is authority @ScienceMagazine @hholdenthorp
science.org/doi/abs/10.1126/…
1
289
Michael Rockman, MD, PhD retweeted
Electronic health records and messages have a major impact on physician workload - though often invisible and underestimated. Report @JCOOP_ASCO show that every patient EHR messages leads to ~7 internal in-basket messages. Contribution to burnout?
ascopubs.org/doi/10.1200/OP-…
8
37
79
27,281
Michael Rockman, MD, PhD retweeted
Colleague was doing a thoracic spine decompression surgery in a medically sick patient. High risk for paralysis or infection.
Nurse enters the room, uninvited, and starts documenting who has uncovered facial hair on her “facial hair noncompliance” clipboard.
Meanwhile, according to open evidence: Operating room traffic (people entering and exiting) has substantially more supporting evidence than uncovered facial hair as a driver of intraoperative surgical site infection (SSI).
That nurse won’t be the one answering to family or facing a lawsuit in case of a complication. Yet she will smugly write up any personnel who fail to comply with her completely arbitrary rules.
72
55
808
94,110
First week patching in six years! A lot like riding a bike with a lot more broken pipettes.
Glad to be back in the lab starting my postdoc with @hERGologie
2
12
718
Michael Rockman, MD, PhD retweeted
Why do we feel the need to review manuscripts for journals and have to critique and suggest changes like the authors must be subjected to some hazing ritual? Honestly I read so many as a reviewer and I’m like, it’s fine, not the best, but pretty good, what do you want from me
12
17
237
20,323
High-quality mentorship can improve physician-scientist recruitment, retention, and career satisfaction @TheLancet
thelancet.com/journals/lance…
1
4
453
Michael Rockman, MD, PhD retweeted
Breaking and MASSIVE:
Lowering Lp(a) with #pelacarsen in patients with elevated Lp(a) and heart disease does NOT improve cardiovascular outcomes in Phase 3 trial globenewswire.com/news-relea…
46
166
579
210,361
Michael Rockman, MD, PhD retweeted
The issue with AI assistance in academic writing, design, etc.:
You need to ignore about half of its suggestions. The problem for early-stage researchers is that they usually don’t know which half.
8
27
238
18,891
Michael Rockman, MD, PhD retweeted
I once had a fellow med student who’s research task was to reorganize the freezer… like of course they hated “research”
AND it hurts students. Med students often do boring, menial research tasks for authorship and it makes them hate research. They often aren’t involved in the curiosity, questions, and investigation that makes research fun. We then loose many talented minds who write research off.
5
3
143
13,465
Michael Rockman, MD, PhD retweeted
We've not understood why SGLT2 drugs (like empagliflozin, Jardiance) have marked protective heart benefit.
Today @ScienceMagazine a mechanism unraveled for improving cardiac metabolism and fuel efficiency
science.org/doi/10.1126/scie…
18
278
1,012
75,984
Michael Rockman, MD, PhD retweeted
Yes it sucks to spend $200 on a bad antibody. That undoubtedly adds to the cost of doing research. But the total costs of this fraud are *MUCH* larger.
Most people recognize the enormous *time* cost of this fraud - every basic scientist has wasted days trying to make bad antibodies work. But what productive use could that time have been used for? What discoveries *weren’t* made because of this? (Opportunity cost)
It’s even harder to measure the cost of false positives. How many drug candidates made it to phase 1 testing because of bad antibodies? Is this why so many drugs fail in phase 1?
How many patients were harmed by ineffective therapies developed using bad antibodies? (Human cost)
How many hundreds of billions do failed phase 1 studies add to the cost of drug development, and indirectly to overall healthcare costs?
We’re all paying for this fraud whether you’ve ever pipetted or not. The companies that are deliberately selling bad antibodies should be held accountable for these costs.
"More than 18,000 questionable images found in antibody catalogues of 15 companies" - It's stuff like this that makes bio research so slow
10
70
464
41,094
Michael Rockman, MD, PhD retweeted
No free lunch. In our meta-analysis, now published in JAMA Cardiology, transcatheter left atrial appendage closure (LAAC) was associated with similar long-term risks of any stroke and major bleeding compared with oral anticoagulation in patients with atrial fibrillation, while increasing the risk of ischemic stroke and reducing the risk of nonprocedure-related major bleeding.
Article: jamanetwork.com/journals/jam…
Editorial: jamanetwork.com/journals/jam…
8
78
251
33,778
RT @modirshanechi: I'm SO SICK of the shameless use of LLMs to spit out garbage papers that merely look legitimate. It's a waste of everyon…
30
1
Michael Rockman, MD, PhD retweeted
We need to change the ABIM rules so that short trackers can sit for the internal medicine boards upon completing internal medicine residency. It makes no sense to make short trackers wait an extra year before taking the exam, despite having completed the training for it.
5
2
91
12,118
Michael Rockman, MD, PhD retweeted
LLM use in biomedical papers since the launch of ChatGPT 🚀
9
11
74
9,522
Michael Rockman, MD, PhD retweeted
"Rest is not the opposite of good work. It is the source of it. We need reminders that we are not only what we produce."
In a #PieceofMyMind, a hospital chaplain considers how #healthcare work is shaped not only by what #clinicians give, but also by what they receive from patients, colleagues, and moments of restoration. The essay supports replenishment as necessary to sustain work grounded in presence, vulnerability, and care.
ja.ma/3UclHSg
4
11
47
9,832
Genetic Research on Cardiac Channelopathies in African and African-Descent Populations @JAHA_AHA
ahajournals.org/doi/10.1161/…
1
336
Michael Rockman, MD, PhD retweeted
In the 2026 US #InternalMedicine workforce, non-US-born #physicians accounted for nearly half of board-certified physicians, including substantial shares across subspecialties such as #geriatrics, #nephrology, and #sleep #medicine.
These findings indicate that immigration policy changes could affect workforce capacity in specialties that rely heavily on non-US-born international medical graduates.
ja.ma/4fOwV7W
6
33
124
69,555
Michael Rockman, MD, PhD retweeted
Get rid of the term "provider" in health care!
The need and steps for action.
@AnnalsofIM
acpjournals.org/doi/10.7326/…
14
103
357
82,623